HIV 1 News and Research

RSS

Hebrew University student develops drug formulations to treat illnesses through skin applications

New, more efficient drug formulations designed to treat illnesses through skin applications -- thus avoiding serious side effects associated with oral drug-taking -- have been developed by a student at the Hebrew University of Jerusalem.

12 Jun 2013

Johns Hopkins researchers develop experimental vaccine for TB meningitis

A team of Johns Hopkins researchers working with animals has developed a vaccine that prevents the virulent TB bacterium from invading the brain and causing the highly lethal condition TB meningitis, a disease that disproportionately occurs in TB-infected children and in adults with compromised immune system.

12 Jun 2013

Study explores various strategies, suggests cost-effective options for HIV testing in India

In India most people who are HIV positive don't know it, yet testing and treatment are relatively cheap and available. It would therefore meet international standards of cost-effectiveness - and save millions of lives for decades - to test every person in the billion-plus population every five years according to a new study published in the journal PLoS One.

11 Jun 2013

3 out of 20 GI endoscopes used for screening harbor unacceptable levels of "bio dirt"

Three out of 20 flexible gastrointestinal (GI) endoscopes used for screening were found to harbor unacceptable levels of "bio dirt" - cells and matter from a patient's body that could pose potential infection risk -- according to a study of endoscopes used at five hospitals across the U.S.

10 Jun 2013

BioLineRx signs out-licensing agreement with CTTQ to develop, commercialize Hepatitis C drug

BioLineRx, a biopharmaceutical development company, announced today that it has signed an out-licensing agreement with Jiangsu Chia-tai Tianqing Pharmaceutical Co., Ltd., the leading Chinese pharmaceutical company in the liver disease therapeutic area, for the development and commercialization of BL-8030, an orally available treatment for the Hepatitis C virus.

10 Jun 2013

Faldaprevir+ achieves viral cure in 88% of treatment-naïve genotype-1 hepatitis C patients in Asia

New findings presented today during the APASL Liver Week in Singapore, highlighted the efficacy and safety of faldaprevir+ plus pegylated interferon and ribavirin (PegIFN/RBV) in treatment-naïve patients with genotype-1 hepatitis C virus (HCV) in Asia.1 This post-hoc sub-analysis of the Phase III STARTVerso™1 and 2 trials showed that both doses of faldaprevir were associated with high viral cure rates and a shorter treatment duration in this particular patient group.1

10 Jun 2013

New revolutionary HIV test provides results in one minute

On Saturday, June 8th, AIDS Healthcare Foundation (AHF) will make history as the first HIV testing program in New York City to use a revolutionary HIV test that provides results to people in just one minute.

7 Jun 2013

Viewpoints: 'Reasonable' debate about health law's 'rate shock; 'absurdity' of Sebelius' account of fund raising; Obama killed the grand bargain

Many of us have been wondering whether it's possible to have an honest, reasonable debate about Obamacare. To my pleasant surprise, one may finally be starting.

7 Jun 2013

Cow antibodies points to new ways for making human medicines

Humans have been raising cows for their meat, hides and milk for millennia. Now it appears that the cow immune system also has something to offer. A new study led by scientists from The Scripps Research Institute (TSRI) focusing on an extraordinary family of cow antibodies points to new ways to make human medicines.

7 Jun 2013

$Epidural steroid injection is associated with increased spinal fracture$

Epidural steroid injection is associated with increased spinal fracture

Most aging adults will experience back pain or a spinal disorder at some time in their life. In fact, about 25.8 million visits were made to physicians' offices due to primary back problems. Treatment focuses on pain relief and is available in both non-surgical (medication or physical therapy) and surgical forms.

7 Jun 2013

Low levels of vitamin D associated with high levels of hepatitis B virus replication

Researchers from Germany have found that low levels of vitamin D are associated with high levels of hepatitis B virus replication. Findings published online in Hepatology, a journal of the American Association for the Study of Liver Diseases, suggest seasonal fluctuations in vitamin D and HBV levels point to a link in these variables among patients with chronic HBV.

6 Jun 2013

Research reveals how HIV triggers signal to kill infected immune cell

Untreated HIV infection destroys a person's immune system by killing infection-fighting cells, but precisely when and how HIV wreaks this destruction has been a mystery until now. New research by scientists at the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, reveals how HIV triggers a signal telling an infected immune cell to die.

6 Jun 2013

New plug-in optical sensor can help diagnose Kaposi's sarcoma

As antiretroviral drugs that treat HIV have become more commonplace, the incidence of Kaposi's sarcoma, a type of cancer linked to AIDS, has decreased in the United States.

5 Jun 2013

Duke University is awarded $2M to initiate new clinical research network on antibacterial resistance

Duke University, Durham, N.C., has been awarded $2 million to initiate a new clinical research network focused on antibacterial resistance. Total funding for the leadership group cooperative agreement award could reach up to $62 million through 2019.

4 Jun 2013

Duke Medicine, UCSF investigators to oversee research program on antibacterial resistance

Investigators at Duke Medicine and the University of California, San Francisco have been selected to oversee a nationwide research program on antibacterial resistance, which includes a focus on the growing unmet challenges associated with methicillin-resistant Staphylococcus aureus and E. coli.

4 Jun 2013

CWRU nursing school receives NINR grant to support palliative care

Medical advancements that extend the lives of patients with cancer, heart failure and other serious chronic diseases have created another need: more clinicians skilled in specialized care for people with terminal illnesses.

4 Jun 2013

Mathematical modeling proved critical in understanding latent stage of infections

Recurrent infection is a common feature of persistent viral diseases. It includes episodes of high viral production interspersed by periods of relative quiescence. These quiescent or silent stages are hard to study with experimental models. Mathematical analysis can help fill in the gaps.

3 Jun 2013

GRACE study reports colored women are poorly represented in HIV drug trials

Enrollment of women in clinical trials of new anti-HIV drugs is extremely low, representing only about 15% of all treatment-experienced patients. For women of color it is even lower.

3 Jun 2013

New research examines treatment outcomes of HIV-positive transgender people

HIV-positive transgender people are just as likely to stay in care, take their medication and have similar outcomes as other men and women living with the disease, according to new research from the Perelman School of Medicine at the University of Pennsylvania and published online May 30 in Clinical Infectious Diseases.

3 Jun 2013

Food insecurity increases risk of death among injection drug users living with HIV/AIDS

Food insecurity increases the risk of death among injection drug users living with HIV/AIDS even when they are receiving life-prolonging antiretroviral therapy (ART), according to a new study involving Simon Fraser University.

1 Jun 2013

HIV 1 News and Research

Hebrew University student develops drug formulations to treat illnesses through skin applications

Johns Hopkins researchers develop experimental vaccine for TB meningitis

Study explores various strategies, suggests cost-effective options for HIV testing in India

3 out of 20 GI endoscopes used for screening harbor unacceptable levels of "bio dirt"

BioLineRx signs out-licensing agreement with CTTQ to develop, commercialize Hepatitis C drug

Faldaprevir+ achieves viral cure in 88% of treatment-naïve genotype-1 hepatitis C patients in Asia

New revolutionary HIV test provides results in one minute

Viewpoints: 'Reasonable' debate about health law's 'rate shock; 'absurdity' of Sebelius' account of fund raising; Obama killed the grand bargain

Cow antibodies points to new ways for making human medicines

Epidural steroid injection is associated with increased spinal fracture

Low levels of vitamin D associated with high levels of hepatitis B virus replication

Research reveals how HIV triggers signal to kill infected immune cell

New plug-in optical sensor can help diagnose Kaposi's sarcoma

Duke University is awarded $2M to initiate new clinical research network on antibacterial resistance

Duke Medicine, UCSF investigators to oversee research program on antibacterial resistance

CWRU nursing school receives NINR grant to support palliative care

Mathematical modeling proved critical in understanding latent stage of infections

GRACE study reports colored women are poorly represented in HIV drug trials

New research examines treatment outcomes of HIV-positive transgender people

Food insecurity increases risk of death among injection drug users living with HIV/AIDS

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Automating research - solutions and best practices

Latest News